BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 4211573)

  • 41. [Prospects of the clinical use of immunosuppressive agents in control of materno-fetal Rh isoimmunization and in attempted prevention. (Theoretical presuppositions and preliminary clinical experiences)].
    Vecchietti G; Onnis A
    Minerva Ginecol; 1970 May; 22(9):459-62. PubMed ID: 4995415
    [No Abstract]   [Full Text] [Related]  

  • 42. Some residual problems concerning Rh prophylaxis.
    Finn R
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):436-9. PubMed ID: 5003521
    [No Abstract]   [Full Text] [Related]  

  • 43. The management of Rh-Isoimmunization.
    Bowman JM
    Obstet Gynecol; 1978 Jul; 52(1):1-16. PubMed ID: 98742
    [No Abstract]   [Full Text] [Related]  

  • 44. [Incidence of erythroblastosis in the umbilical cord blood of newborn infants with materno-fetal Rh factor incompatibility without signs of isoimmunization].
    Moscatelli P; Pantarotto F; Melevendi C
    Minerva Pediatr; 1967 Oct; 19(43):1901-2. PubMed ID: 4974603
    [No Abstract]   [Full Text] [Related]  

  • 45. [Successful prevention of rhesus immunization by anti-D immunoglobulin after a massive fetomaternal transfusion. Apropos of a case].
    Schlaeder G; Kuhn A; De Mot E; Burger JP; Dellenbach P; Gandar R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(2):240. PubMed ID: 4107714
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immunoprophylaxis of neonatal hemolytic disease caused by Rh incompatibility. Analysis of a 5-year experience].
    Sansone G; Veneziano G; Mantegazza F; Cominetti M
    Pathologica; 1974; 66(961-962):477-89. PubMed ID: 4141760
    [No Abstract]   [Full Text] [Related]  

  • 47. [New information about the prevention of Rh isoimmunization].
    Tesauro G
    Minerva Ginecol; 1968 May; 20(10):847-50. PubMed ID: 4186920
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical aspects in the prevention of antibody formation with anti-D-immunoglobulin].
    Frey P; Hinselmann M; Hindemann P
    Gynaecologia; 1969; 167(5):280-4. PubMed ID: 4184764
    [No Abstract]   [Full Text] [Related]  

  • 49. Effectiveness of Rh prophylaxis.
    Woodrow JC
    Haematologia (Budap); 1974; 8(1-4):281-90. PubMed ID: 4218822
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immuno-hematology of obstetrical importance. (Technical notes)].
    Furfaro M
    Minerva Ginecol; 1970 Jan; 22(1):31-47. PubMed ID: 4987993
    [No Abstract]   [Full Text] [Related]  

  • 51. [Studies on the demonstration of fetal erythrocytes in the maternal blood during the postpartum period].
    Cordier P; Madeline P; Guillaumin JP; Jeanney JC; Couzineau P
    Ann Biol Clin (Paris); 1967; 25(7):903-11. PubMed ID: 4965531
    [No Abstract]   [Full Text] [Related]  

  • 52. [Current status of prevention of Rh-isoimmunization at the Obstetric and Gynecological Clinic of the University of Naples].
    Paladini A; Rascio B; Di Lieto A; Tinelli FG
    Arch Ostet Ginecol; 1970; 75(5):367-74. PubMed ID: 5003501
    [No Abstract]   [Full Text] [Related]  

  • 53. Results of Rh-sensitization prophylaxis and research into standardization of immunoglobulin-anti-D.
    Schneider J
    Prog Immunobiol Stand; 1970; 4():284-90. PubMed ID: 4098266
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prevention of feto-maternal isoimmunization, in particular by means of anti-Rh immunoglobulins].
    de Muralt G
    Rev Fr Transfus; 1969 Mar; 12(1):61-84. PubMed ID: 4180270
    [No Abstract]   [Full Text] [Related]  

  • 55. [Problems in anti-rhesus (D) immunoprophylaxis].
    Bennebroek Gravenhorst J; Overbeeke MA; van Dijk BA
    Ned Tijdschr Geneeskd; 1984 May; 128(21):1005-9. PubMed ID: 6429554
    [No Abstract]   [Full Text] [Related]  

  • 56. Rh-immune globulin after amniocentesis for genetic diagnosis.
    Henry G; Wexler P; Robinson A
    Obstet Gynecol; 1976 Nov; 48(5):557-9. PubMed ID: 824587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Letter: Prevention of feto-maternal Rhesus incompatibility].
    Senecal J; Garnier H; Le Marec B; Le Bonniec Y
    Nouv Presse Med; 1976 Apr; 5(17):1146. PubMed ID: 819907
    [No Abstract]   [Full Text] [Related]  

  • 58. [Improved prognosis of fetal erythroblastosis through the variation of prophylactic and therapeutic measures].
    Verron G; Radzuweit H; Schubert W; Brockmann J
    Dtsch Gesundheitsw; 1970 Oct; 25(40):1906-10. PubMed ID: 4991821
    [No Abstract]   [Full Text] [Related]  

  • 59. Proceedings: Plasmapheresis in rhesus disease.
    Graham-Pole J
    Scott Med J; 1975 Jul; 20(4):168-9. PubMed ID: 808852
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prevention of Rh isoimmunization].
    Vedra B; Smeral P
    Cesk Pediatr; 1971 Jun; 26(6):307-8. PubMed ID: 4996776
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.